Y-mAbs Therapeutics, Inc. (YMAB) Investor Alert: Robbins
SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all...
Source: globenewswire.com
Page 6 - Briefing Document News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Briefing Document. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Briefing Document Today - Breaking & Trending Today
Y-MABS THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Y-mAbs Therapeutics, Inc.
/PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 20, 2023 to file lead plaintiff applications...
Source: prnewswire.com
Y-MABS INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Y-mAbs To Contact Him Directly To Discuss Their Options
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Y-mAbs Therapeutics, Inc. ("Y-mAbs" or...
Source: prnewswire.com
Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB)
/PRNewswire/ -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the...
Source: prnewswire.com
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) Investor Alert:
NEW YORK, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing its investigation of claims on behalf of...
Source: globenewswire.com